Orally administered TQ-A3334 to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics single and multiple ascending doses in healthy Chinese subjects

被引：0
|
作者：
Hu, Yue [1 ]
Zhang, Hong [1 ]
Wu, Min [1 ]
Huo, Dandan [2 ]
Chen, Hong [1 ]
Li, Xiaojiao [1 ]
Xu, Zhongnan [2 ]
Ding, Yanhua [1 ]
Niu, Junqi [3 ]
机构：
[1] Jilin Univ, Phase Clin Res Ctr 1, Hosp 1, Changchun, Jilin, Peoples R China
[2] Chiatai Tianqing Pharmaceut Co Ltd, Changchun, Jilin, Peoples R China
[3] Jilin Univ, Hosp 1, Changchun, Jilin, Peoples R China
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)30921-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-176
引用
收藏
页码：E466 / E467
页数：2
相关论文
共 50 条
  • [31] Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults
    Courtney, R
    Pai, S
    Laughlin, M
    Lim, J
    Batra, V
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (09) : 2788 - 2795
  • [32] Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers
    Yingxin Li
    Yang Li
    Li Li
    Wei Xue
    Kong Xin
    Titi Wang
    Aixin Shi
    Clinical Drug Investigation, 2023, 43 (6) : 413 - 420
  • [33] Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers
    Li, Yingxin
    Li, Yang
    Li, Li
    Xue, Wei
    Xin, Kong
    Wang, Titi
    Shi, Aixin
    CLINICAL DRUG INVESTIGATION, 2023, 43 (06) : 413 - 420
  • [34] Safety, tolerability, pharmacokinetics and pharmacodynamics of dexlansoprazole injection in healthy Chinese subjects
    Yue-Qi Li
    Zheng-Yu Yan
    Hong-Wen Zhang
    Lu-Ning Sun
    Hui-Wen Jiao
    Mei-Feng Wang
    Li-Yuan Yu
    Lei Yu
    Zi-Qing-Yun Yuan
    Ling Meng
    Yong-Qing Wang
    European Journal of Clinical Pharmacology, 2017, 73 : 547 - 554
  • [35] Safety, tolerability, pharmacokinetics and pharmacodynamics of dexlansoprazole injection in healthy Chinese subjects
    Li, Yue-Qi
    Yan, Zheng-Yu
    Zhang, Hong-Wen
    Sun, Lu-Ning
    Jiao, Hui-Wen
    Wang, Mei-Feng
    Yu, Li-Yuan
    Yu, Lei
    Yuan, Zi-Qing-Yun
    Meng, Ling
    Wang, Yong-Qing
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (05) : 547 - 554
  • [36] Pharmacokinetics, pharmacodynamics and tolerability of the glucokinase activator AZD1656, after single ascending doses in healthy subjects
    Leonsson-Zachrisson, M.
    Norjavaara, E.
    Wollbratt, M.
    Persson, M.
    Alstrom, A. -M.
    Ueda, S.
    Roshammar, D.
    Ericsson, H.
    DIABETOLOGIA, 2011, 54 : S361 - S361
  • [37] A study to evaluate the safety, tolerability, and pharmacokinetics of multiple weekly doses of intravenous dalbavancin in healthy subjects
    Dunne, Michael W.
    Sprenger, Craig
    Moriarty, Susan
    PHARMACOTHERAPY, 2013, 33 (10): : E261 - E261
  • [38] Safety, pharmacokinetics (PK), and pharmacodynamics (PD) of ascending multiple doses of SRA-333 in healthy subjects
    Raje, SV
    Plotka, A
    Parks, V
    Patat, A
    Chassard, D
    NEUROBIOLOGY OF AGING, 2004, 25 : S215 - S215
  • [39] Pharmacokinetics and pharmacodynamics of intravenous ilaprazole in healthy subjects after single ascending doses
    Wang, Hongyun
    Ou, Ning
    Lang, Liwei
    Shi, Ruihua
    Hu, Pei
    Jiang, Ji
    XENOBIOTICA, 2016, 46 (12) : 1133 - 1141
  • [40] Safety, pharmacokinetics (PK), and pharmacodynamics (PD) of ascending single doses of SRA-333 in healthy subjects
    Plotka, A
    Parks, V
    Raje, S
    Patat, A
    Chassard, D
    NEUROBIOLOGY OF AGING, 2004, 25 : S212 - S212
12345